Clinical Trial Update: Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial comparing OPC-61815 injection to tolvaptan in congestive heart failure completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• OPC-61815
• tolvaptan (tolvaptan)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Congestive Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2021-08-05